Karl Swedberg


Institute of Medicine
Visiting address
Room number
Postal address
SU Sahlgrenska
413 45 Göteborg

About Karl Swedberg

Karl Swedberg, MD, PhD, FESC, is Senior Professor of Cardiology and Care Science, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden. He is a Scientific Advisor to the University of Gothenburg Centre for Person Centred Care (GPCC). He was the first to report on survival benefits of a beta-blocker (1979), an ACE-inhibitor (1987), an angiotensinreceptor blocker (2003) and recently an ARNI (angiotensin receptor antagonist and neprilysin inhibitor 2014) in chronic heart failure. He has published widely in international journals with more than 600 publications in peer-reviewed journals, 340 original research papers and > 65000 citations.

He was Chairman of the Task Force on the Diagnosis and Treatment of Chronic Heart Failure that updated the ESC Guidelines 2005. He has participated in Steering Committees in numerous outcome trials in myocardial infarction and heart failure.

Rewards and distinctions

  • Recipient of the 2004 Kaufman Award of heart failure research from Cleveland Clinics, USA.
  • Awarded European Society of Cardiology (ESC) Gold medal 2007 for outstanding contributions to the cardiovascular field.
  • He gave the Paul Dudley White international lecture, AHA annual meeting in Orlando 2009.
  • "Lifetime Achievement Award" from Heart Failure Association (HFA) of ESC in 2016.
  • Member of the Editorial Board of several international journals.
  • 2005-2009 he served as Editor-in-Chief of the European Journal of Heart Failure.
  • He is Associate Editor in European Heart Journal since 2012.
  • Among Highly cited 2017-2019